Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 5
1995 10
1996 5
1997 7
1998 7
1999 4
2000 2
2001 6
2002 5
2003 4
2004 3
2005 5
2006 5
2007 10
2008 2
2009 7
2010 9
2011 9
2012 17
2013 22
2014 16
2015 21
2016 12
2017 19
2018 14
2019 16
2020 26
2021 32
2022 21
2023 27
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Results by year

Filters applied: . Clear all
Page 1
Dornase Alfa.
[No authors listed] [No authors listed] 2021 Jun 21. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Jun 21. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999662 Free Books & Documents. Review.
A task force respiratory experts from Europe, Australia and New Zealand found that dornase alfa is compatible with breastfeeding.[1]...
A task force respiratory experts from Europe, Australia and New Zealand found that dornase alfa is compatible with breastfeedi …
Dornase Alfa.
Altaf R, Parmar M. Altaf R, et al. 2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32310478 Free Books & Documents.
The disease primarily affects patients' upper and lower airways, causes long-lasting lung infections, and limits the ability to breathe over time. Dornase alfa is an inhaled medication that thins mucus, used to manage and treat cystic fibrosis. ...This activity outl …
The disease primarily affects patients' upper and lower airways, causes long-lasting lung infections, and limits the ability to breathe over …
Dornase alfa for cystic fibrosis.
Yang C, Montgomery M. Yang C, et al. Cochrane Database Syst Rev. 2018 Sep 6;9(9):CD001127. doi: 10.1002/14651858.CD001127.pub4. Cochrane Database Syst Rev. 2018. PMID: 30187450 Free PMC article. Updated. Review.
MAIN RESULTS: The searches identified 69 trials, of which 19 (2565 participants) met our inclusion criteria. Fifteen trials compared dornase alfa to placebo or no dornase alfa (2447 participants); two compared daily dornase to hypertonic saline (32 par …
MAIN RESULTS: The searches identified 69 trials, of which 19 (2565 participants) met our inclusion criteria. Fifteen trials compared dorn …
Dornase alfa (Pulmozyme).
Wagener JS, Kupfer O. Wagener JS, et al. Curr Opin Pulm Med. 2012 Nov;18(6):609-14. doi: 10.1097/MCP.0b013e328358d51f. Curr Opin Pulm Med. 2012. PMID: 22990660 Review.
As other respiratory medications have entered the clinical market, understanding the proper use and indication for dornase alfa is increasingly important. In addition, dornase alfa is being used to treat other medical conditions. ...Most importantly, r …
As other respiratory medications have entered the clinical market, understanding the proper use and indication for dornase alfa …
Dornase alfa for cystic fibrosis.
Yang CL, Chilvers M, Montgomery M, Nolan SJ. Yang CL, et al. Paediatr Respir Rev. 2017 Jan;21:65-67. doi: 10.1016/j.prrv.2016.09.001. Epub 2016 Sep 15. Paediatr Respir Rev. 2017. PMID: 27769785 Review. No abstract available.
Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index.
Terlizzi V, Castellani C, Taccetti G, Ferrari B. Terlizzi V, et al. Ital J Pediatr. 2022 Aug 4;48(1):141. doi: 10.1186/s13052-022-01331-5. Ital J Pediatr. 2022. PMID: 35927765 Free PMC article. Review.
So far, symptomatic mucolytic therapy is mainly based on inhalation of dornase alfa, hypertonic saline or mannitol, in combination with physiotherapy. ...In this review we will summarize the current knowledge on dornase alfa in the treatment of CF lung …
So far, symptomatic mucolytic therapy is mainly based on inhalation of dornase alfa, hypertonic saline or mannitol, in combina …
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
Mayer-Hamblett N, Ratjen F, Russell R, Donaldson SH, Riekert KA, Sawicki GS, Odem-Davis K, Young JK, Rosenbluth D, Taylor-Cousar JL, Goss CH, Retsch-Bogart G, Clancy JP, Genatossio A, O'Sullivan BP, Berlinski A, Millard SL, Omlor G, Wyatt CA, Moffett K, Nichols DP, Gifford AH; SIMPLIFY Study Group. Mayer-Hamblett N, et al. Lancet Respir Med. 2023 Apr;11(4):329-340. doi: 10.1016/S2213-2600(22)00434-9. Epub 2022 Nov 4. Lancet Respir Med. 2023. PMID: 36343646 Free PMC article. Clinical Trial.
The SIMPLIFY study aimed to assess the effects of discontinuing nebulised hypertonic saline or dornase alfa in individuals using the CFTR modulator elexacaftor plus tezacaftor plus ivacaftor (ETI). ...We included individuals with cystic fibrosis aged 12-17 years wit …
The SIMPLIFY study aimed to assess the effects of discontinuing nebulised hypertonic saline or dornase alfa in individuals usi …
Dornase alfa for cystic fibrosis.
Yang C, Chilvers M, Montgomery M, Nolan SJ. Yang C, et al. Cochrane Database Syst Rev. 2016 Apr 4;4:CD001127. doi: 10.1002/14651858.CD001127.pub3. Cochrane Database Syst Rev. 2016. PMID: 27043279 Updated. Review.
Three additional papers examined the healthcare cost from one of the clinical trials. Fifteen trials compared dornase alfa to placebo or no dornase alfa treatment (2447 participants); two compared daily dornase to hypertonic saline (32 participants); o …
Three additional papers examined the healthcare cost from one of the clinical trials. Fifteen trials compared dornase alfa to …
Dornase alfa for cystic fibrosis.
Yang C, Montgomery M. Yang C, et al. Cochrane Database Syst Rev. 2021 Mar 18;3(3):CD001127. doi: 10.1002/14651858.CD001127.pub5. Cochrane Database Syst Rev. 2021. PMID: 33735508 Free PMC article.
MAIN RESULTS: The searches identified 74 trials, of which 19 (2565 participants) met our inclusion criteria. 15 trials compared dornase alfa to placebo or no dornase alfa (2447 participants); two compared daily dornase to hypertonic saline (32 particip …
MAIN RESULTS: The searches identified 74 trials, of which 19 (2565 participants) met our inclusion criteria. 15 trials compared dornase …
311 results

Searches related to "dornase alfa"